about
Current status of biomarker research in neurologyDisruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.Mechanisms of Autoantibody-Induced Pathology.Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersAquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disordersInsufficient treatment of severe depression in neuromyelitis optica spectrum disorder.Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report.Myopathy associated with neuromyelitis optica spectrum disorders.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.Astrocytes in multiple sclerosis.Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy.Cortical blindness and not optic neuritis as a cause of vision loss in a Sjögren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD): Challenges of ascribing demyelinating syndromes to SS: a case reportThe binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosisNeuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4.Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.A population-based prospective study of optic neuritis.Pattern Recognition of the Multiple Sclerosis Syndrome.Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.The Gut Microbiome in Neuromyelitis Optica.Brain MRI findings in patients with idiopathic hypersomnia.Orbital Ectopic Lymphoid Follicles with Germinal Centers in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.Fatigue as a symptom or comorbidity of neurological diseases.
P2860
Q26744505-AC442BF0-9473-47B1-9284-3C65D3591220Q33592132-7C0E9549-3099-4C8B-91BE-9EB26FA77D4CQ33719007-2AE62B70-1220-4316-B446-3C74A5A217BAQ33740580-FE615DB4-0245-4F84-8325-E70E961758BFQ33808279-6AD4DD19-545F-451E-93A6-C79B0880F9A2Q36484394-CE5BC435-34EC-49BC-8E68-8DF0E4457182Q37015396-78BEE45F-1999-4EEE-9D27-D83844E57663Q37059594-623B2EB4-CDE1-46FD-A10E-4108276189B0Q37365089-FF8A31B3-8D19-4B10-B4E7-75448BBD2A87Q37534144-66B07C9D-7288-4241-9915-F50CF0F2F602Q37590294-7CB62C90-3839-433C-98F5-7C9E54E06BB3Q37645937-D0D10710-B614-4280-A264-622DB234EC51Q37661860-35EFA82C-6C84-4F45-8605-7A64560B8302Q37709549-B2A13207-B686-4CA5-9792-B772C4F7E9BDQ38619559-FC253FE6-C59F-4A63-B69C-1E755F30885DQ38661867-E997EE47-4380-485F-B049-01FEF42B09FEQ38750021-C2E78F96-15CD-415E-A507-3762E4AB6814Q38831970-77FDCD1D-3B28-4559-94FC-DA871390137DQ38840390-F8428518-BE3F-42DD-A99F-C5E5316426A6Q38929223-0A8B2BFC-4CF4-458C-938D-2113BAD155F3Q39442792-3DDF8558-3C3E-407E-ADEB-06D2F78EB75EQ41381386-0A93081A-6DCE-4EEF-B49E-28FCBBD20078Q41523649-50DE49B4-A0E5-497E-96A0-75542158D9EDQ41683003-8947626F-701B-4C0C-B3A9-59041B4AB9A6Q41831300-0D2D2C53-B953-4354-838D-2A5CFA66718CQ41992411-5BC84CF2-1982-4381-A0D7-C56EC1D6679EQ42361527-6F6A65DC-A934-4560-9B29-E855C6E31079Q42364252-3F3ABF30-C9F1-4908-8CF0-D31A6D8E85BCQ42511488-DD3F468D-32A9-40A4-8DAA-04EC1B2E58C0Q42694999-812BFF0B-C733-4987-A663-766BBF6E1802Q47096340-54D76319-9A87-46E7-A721-C0D52073BE7EQ47104784-C5A80144-99E5-4CA2-B694-5421EFC911A1Q47163794-27ECCD0D-0099-490F-9287-C37D5AC8F040Q47192132-1C78501F-6CA9-41C3-820F-A9C8422C851FQ47252742-9B2CC95D-4C7F-4D11-A612-768A550738C2Q47745620-1D3A8C19-F34F-45D3-B73C-4B1E8F5BF067Q47827665-DD4ADB1C-2ADF-47A1-8E2B-D8C5F0F0E7BFQ47898192-E2F7DAF0-E742-4C42-8E32-F0999C8BF306Q48445648-879258E4-A0BD-4090-8F80-A98412C79BBFQ50063088-E31CB03D-BE3C-4FC6-9432-F2B2E0240CC5
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Aquaporin-4 autoimmunity
@ast
Aquaporin-4 autoimmunity
@en
Aquaporin-4 autoimmunity
@nl
type
label
Aquaporin-4 autoimmunity
@ast
Aquaporin-4 autoimmunity
@en
Aquaporin-4 autoimmunity
@nl
prefLabel
Aquaporin-4 autoimmunity
@ast
Aquaporin-4 autoimmunity
@en
Aquaporin-4 autoimmunity
@nl
P2860
P3181
P1476
Aquaporin-4 autoimmunity
@en
P2093
Anastasia Zekeridou
Vanda A Lennon
P2860
P3181
P356
10.1212/NXI.0000000000000110
P407
P577
2015-08-01T00:00:00Z